Prognosis of patients with heart failure and reduced ejection fraction in China

Yu Xu1, Yanan Shi, Zhongyu Zhu

  • 1Department of Cardiology, Henan Province People's Hospital, The People's Hospital of Zhengzhou University, Zhengzhou, Henan 450003, P.R. China.

Insights

Patients with heart failure with reduced ejection fraction (HFrEF) in China face poor prognoses, especially those with left ventricular ejection fraction (LVEF) ≤35%. Optimal medication use and guideline adherence are crucial for improving survival rates in these patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Chronic heart failure (HF) with reduced ejection fraction (HFrEF) poses a significant health burden globally.
  • Understanding survival rates and medication adherence in specific populations, like Chinese patients, is critical for effective management.
  • Reduced ejection fraction (HFrEF) is a key indicator of cardiac dysfunction and impacts patient prognosis.

Purpose of the Study:

  • To investigate the 5-year survival and medication status of patients with HFrEF in China.
  • To identify predictors of mortality in this patient cohort.
  • To compare outcomes between patients with different levels of reduced ejection fraction (LVEF ≤35% vs. LVEF 36-45%).

Main Methods:

  • Single-center, retrospective study enrolling 685 patients with HFrEF (LVEF ≤45%).
  • Patients were divided into two groups: LVEF ≤35% (n=371) and LVEF 36-45% (n=314).
  • Follow-up for a median of 31 months; Cox regression and Kaplan-Meier analyses were used to assess mortality predictors and survival times.

Main Results:

  • Overall mortality was 28% (19% due to pump failure, 6% sudden death).
  • Predictors of all-cause mortality included advanced age, higher BMI, advanced New York Heart Association functional class, and lack of oral beta-blockers at discharge.
  • Only 24% of patients on ACEI/ARB and 23% on beta-blockers reached maximum tolerated doses.

Conclusions:

  • Patients with HFrEF in China exhibit poor prognoses, particularly those with LVEF ≤35%.
  • Effective management requires optimizing medication titration (ACEI/ARB, beta-blockers) and adherence to HF guidelines.
  • Cardiologists must prioritize guideline-based diagnosis and treatment to improve outcomes for Chinese HF patients.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
5.1K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
807
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2.0K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K